Results 101 to 106 of about 249 (106)

Clinical Efficacy and Safety of Dotinurad, a Novel Selective Urate Reabsorption Inhibitor, in Japanese Hyperuricemic Patients With or Without Gout: Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Confirmatory Phase 2 Study

Clinical and Experimental Nephrology, 2020
Tetsuo Ohashi, Tomomitsu Sasaki, Tatsuo Hosoya   +2 more
exaly  

Dotinurad: A Clinical Pharmacokinetic Study of a Novel, Selective Urate Reabsorption Inhibitor in Subjects With Hepatic Impairment

Clinical and Experimental Nephrology, 2020
Yuji Kumagai, Takayoshi Ito, Shigeki Matsumoto   +2 more
exaly  

Clinical Efficacy and Safety of Dotinurad, a Novel Selective Urate Reabsorption Inhibitor, in Japanese Hyperuricemic Patients With or Without Gout: An Exploratory, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Early Phase 2 Study

Clinical and Experimental Nephrology, 2020
Tetsuo Ohashi, Tomomitsu Sasaki, Tatsuo Hosoya   +2 more
exaly  

Effects of Mild and Moderate Renal Dysfunction on Pharmacokinetics, Pharmacodynamics, and Safety of Dotinurad: A Novel Selective Urate Reabsorption Inhibitor

Clinical and Experimental Nephrology, 2020
Tetsuo Ohashi, Tomomitsu Sasaki, Tatsuo Hosoya   +2 more
exaly  

Open-Label Study of Long-Term Administration of Dotinurad in Japanese Hyperuricemic Patients With or Without Gout

Clinical and Experimental Nephrology, 2020
Tetsuo Ohashi, Tomomitsu Sasaki, Tatsuo Hosoya   +2 more
exaly  

Efficacy of Dotinurad in Patients With Severe Renal Dysfunction

Clinical and Experimental Nephrology
Katsuhito Kato, Osamu Kurihara, Yasushi Miyauchi   +2 more
exaly